MedicarePartD.guide

A non-government resource built from CMS public data

Multiple sclerosis drugs on every 2026 Nevada Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Nevada cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Multiple sclerosis drugs by 2026 Nevada Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-112Wellcare Classic$2.70/moS4802-093Wellcare Value Script$2.70/moS4802-161Humana Value Rx Plan$43.70/moS5884-208HealthSpring Extra Rx$52.60/moS5617-379AARP Medicare Rx Saver from UHC$76.70/moS5921-373HealthSpring Assurance Rx$95.60/moS5617-143SilverScript Choice$97.40/moS5601-058AARP Medicare Rx Preferred from UHC$139.10/moS5921-410Humana Premier Rx Plan$148.70/moS5884-175
KesimptaofatumumabNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 1.6/28dNot coveredNot coveredNot covered
teriflunomidegeneric AubagioTier 4PA32%QL 30/30dTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 4PA34%QL 30/30dNot coveredNot coveredTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 436%QL 30/30dTier 4PA50%QL 30/30d
dimethyl fumarategeneric TecfideraNot coveredTier 4PA31%QL 56/28dTier 4PA40%QL 56/28dNot coveredTier 4PA30%QL 14/30dTier 434%QL 56/28dTier 4PA30%QL 14/30dNot coveredTier 436%QL 56/28dTier 4PA50%QL 14/30d
Vumeritydiroximel fumarateNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
fingolimodgeneric GilenyaTier 3PA25%QL 30/30dTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 3PA18%QL 30/30dNot coveredTier 434%QL 30/30dNot coveredTier 5PA25%QL 30/30dTier 436%QL 30/30dTier 3PA$45.00QL 30/30d
MayzentsiponimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ZeposiaozanimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
MavencladcladribineNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.